Brief: ReShape Lifesciences Q3 Net Income USD -3.534 Million
08/11/2023 21:05
Nov 08 (Reuters) - ReShape Lifesciences Q3 gross profit USD 1.288 million. * Q3 operating expenses USD 5.168 million * Q3 operating income USD -3.88 million * Q3 pretax profit USD -3.531 million * Q3 revenue USD 2.155 million
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity